Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jussi Seppälä
Observed names:
J Seppala,
J. Seppala,
J. Seppälä,
Seppälä Jussi,
Seppälä, Jussi
Institutions:
Social Insurance Institution,
University of Oulu
Observed institutions:
University of Helsinki,
Oulu University Hospital,
Social Insurance Institution,
South Karelia Central Hospital,
Moisio Hospital,
Kymenlaakson keskussairaala,
Etelä-Karjalan sosiaali ja terveyspiiri,
University of Oulu
show all 8
ORCID:
0000-0002-8752-2041
Observed ORCID:
0000-0002-8752-2041
OpenAlex ID:
A5078430226
A meta-analysis and transmission disequilibrium study of association between the dopamine D3 receptor gene and schizophrenia
1998
·
J Williams
, G Spurlock
, et al.
·
Molecular Psychiatry
·
159
Mobile Phone and Wearable Sensor-Based mHealth Approaches for Psychiatric Disorders and Symptoms: Systematic Review
2018
·
Jussi Seppälä
, Ilaria De Vita
, et al.
·
JMIR Mental Health
·
148
PDF
Prevalence of metabolic syndrome in subjects with melancholic and non-melancholic depressive symptoms. A Finnish population-based study
2011
·
Jussi Seppälä
, Mauno Vanhala
, et al.
·
Journal of Affective Disorders
·
52
Association between vitamin b12 levels and melancholic depressive symptoms: a Finnish population-based study
2013
·
Jussi Seppälä
, Hannu Koponen
, et al.
·
BMC Psychiatry
·
48
PDF
Predictors of response to pharmacological treatments in treatment-resistant schizophrenia – A systematic review and meta-analysis
2021
·
Annika Seppälä
, Jenni Pylvänäinen
, et al.
·
Schizophrenia Research
·
39
PDF
Measuring Users’ Receptivity Toward an Integral Intervention Model Based on mHealth Solutions for Patients With Treatment-Resistant Schizophrenia (m-RESIST): A Qualitative Study
2016
·
Elena Huerta-Ramos
, Maria Soledad Escobar-Villegas
, et al.
·
JMIR mhealth and uhealth
·
23
Response to antipsychotic drugs in treatment-resistant schizophrenia: Conclusions based on systematic review
2016
·
C. Molins
, A. Roldán
, et al.
·
Schizophrenia Research
·
19
Vitamin D status and correlates of low vitamin D in schizophrenia, other psychoses and non-psychotic depression – The Northern Finland Birth Cohort 1966 study
2019
·
H. Ikonen
, S. Palaniswamy
, et al.
·
Psychiatry Research
·
18
The determinants and longitudinal changes in vitamin D status in middle-age: a Northern Finland Birth Cohort 1966 study
2021
·
Helmi Ikonen
, Johanna Lumme
, et al.
·
European Journal of Nutrition
·
17
PDF
Moclobemide versus imipramine in depressed out-patients: a double-blind multi-centre study
1993
·
R. Rimón
, J. Jääskeläinen
, et al.
·
International Clinical Psychopharmacology
·
17
Linkage analysis in two schizophrenic families originating from a restricted subpopulation of Finland
1994
·
I. Hovatta
, J. Seppälä
, et al.
·
Psychiatric Genetics
·
16
Association between folate intake and melancholic depressive symptoms. A Finnish population-based study
2012
·
Jussi Seppälä
, Hannu Koponen
, et al.
·
Journal of Affective Disorders
·
15
m-RESIST, a Mobile Therapeutic Intervention for Treatment-Resistant Schizophrenia: Feasibility, Acceptability, and Usability Study
2023
·
Eva Grasa
, Jussi Seppälä
, et al.
·
JMIR Formative Research
·
10
PDF
Early environmental factors and somatic comorbidity in schizophrenia and nonschizophrenic psychoses: A 50-year follow-up of the Northern Finland Birth Cohort 1966
2020
·
Hanna Korpela
, Jouko Miettunen
, et al.
·
European Psychiatry
·
6
PDF
A Method to Compare the Delivery of Psychiatric Care for People with Treatment-Resistant Schizophrenia
2020
·
Anna Alonso-Solís
, Susana Ochoa
, et al.
·
International Journal of Environmental Research and Public Health
·
5
PDF
Do adverse perinatal events predict mortality in schizophrenia during midlife?
2016
·
Nina Rautio
, Jouko Miettunen
, et al.
·
Schizophrenia Research
·
4
Somatic comorbidity and its outcomes in schizophrenia during lifespan
2016
·
J. Seppala
, H. Korpela
, et al.
·
European Psychiatry
·
3
PDF
What do we know about treatment-resistant schizophrenia? – A systematic review
2016
·
A. Seppälä
, J. Miettunen
, et al.
·
European Psychiatry
·
3
[Depression and diet ].
2014
·
Jussi Seppälä
, Anne Kauppinen
, et al.
·
PubMed
·
2
Mobile Therapeutic Attention for Treatment-Resistant Schizophrenia (m-RESIST) Solution for Improving Clinical and Functional Outcomes in Treatment-Resistant Schizophrenia: Prospective, Multicenter Efficacy Study
2025
·
Jussi Seppälä
, Eva Grasa
, et al.
·
JMIR Human Factors
·
1
PDF
Benefits and risks of off label use of antipsychotics in insomnia and anxiety – APSY Oulu project
2021
·
Erika Jääskeläinen
, Marianne Haapea
, et al.
·
Nordic Journal of Psychiatry
·
1
Off-label Prescribing of Antipsychotics – a Questionnaire Survey of Finnish Physicians
2021
·
Jami Pentinlehto
, Marianne Haapea
, et al.
·
DOAJ (DOAJ: Directory of Open Access Journals)
·
1
Results of the m-RESIST feasibility study. A Mobile therapeutic attention for treatment-resistant schizophrenia
2019
·
Eva Grasa
, Anna Alonso-Solís
, et al.
·
International Journal of Integrated Care
·
1
Predictors of response in treatment-resistant schizophrenia – a meta-analysis
2019
·
A. Seppälä
, J. Pylvänäinen
, et al.
·
European Neuropsychopharmacology
·
1
Mobile therapeutic attention for treatment-resistant schizophrenia: a prospective multicenter feasibility study in patients, caregivers and clinicians
2019
·
A. Alonso Solís
, E. Grasa
, et al.
·
European Neuropsychopharmacology
·
1
Show more works
View as search
Works count:
44
Citation count:
661
H-index:
13
I10-index:
14
Year
Topic
Type
